VHL and pheochromocytoma: Usually in pheochromocytoma the missense variations which account for 80–95% [34] of mutations in Type 2 VHL leave pVHL with some residual activity [2] which is in contrast to the possibility of complete abrogation of Elongin C binding in our case.